Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Clarence N. Ahlem0
Richard J. Trauger0
Steven K. White0
Theodore M. Page0
Charles Dowding0
Christopher L. Reading0
Dominick L. Auci0
Dwight R. Stickney0
...
Date of Patent
June 16, 2009
0Patent Application Number
116741280
Date Filed
February 12, 2007
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to the use of compounds to ameliorate or treat a condition such as a cystic fibrosis, neutropenia or other exemplified conditions. Exemplary compounds that can be used include 3β-hydroxy-17β-aminoandrost-5-ene, 3β-hydroxy-16α-fluoro-17β-aminoandrost-5-ene, 3α-hydroxy-16α-fluoro-17β-aminoandrost-5-ene, 3β-hydroxy-16β-fluoro-17β-aminoandrost-5-ene, 1α,3β-dihydroxy-4α-fluoroandrost-5-ene-17-one, 1α,3β,17β-trihydroxy-4α-fluoroandrost-5-ene, 1β,3β-dihydroxy-6α-bromoandrost-5-ene, 1α-fluoro-3β,12α-dihydroxyandrost-5-ene-17-one, 1α-fluoro-3β,4α-dihydroxyandrost-5-ene and 4α-fluoro-3β,6α,17β-trihydroxyandrostane.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
